SWOT Analysis for Suven Life Sciences Ltd. - Weakness

Add SWOT widget to your site/app

Companies with no Debt

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Stock with Low PE (PE < = 10)

Promoter decreasing their shareholding

Companies with growing costs YoY for long term projects

Promoter holding decreased by more than -2% QoQ

Negative profit growth, promoters decreasing shareholding QoQ

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Degrowth in Revenue and Profit

Decline in Net Profit (QoQ)

Declining profits every quarter for the past 2 quarters

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Rising Delivery Percentage Compared to Prev Day

Bullish or Bearish Candlestick Strength - Indices

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks